【2020醫療科技展】SmartLabs Global Launch: Top Taiwan Biotech Startups & ICT/AI Leadership in Life Science
The SmartLabs Global Launch Program invites you to join us at this year's Taiwan Healthcare Expo. SmartLabs is proud to feature presentations from leading industry experts at the cutting edge of Al and digital healthcare technologies. You'll also have the chance to hear from the future of Life Science innovation at our SmartLabs Startup Showcase.
活動介紹
波士頓著名生醫加速器 SmartLabs 進駐新竹生醫園區,打造國際級生醫加速器。台灣具備良好的研發能量與新創環境,SmartLabs 的過往成功經驗能鏈結更多的國際資源,成為新創團隊的一大推進力。期盼透過全球啟動計畫 | Global Launch Program,將更多具有潛力的新技術帶向成功之道。
12月04日我們將推舉21家優秀新創,一同向您展示 Medical Device、Therapeutics、Digital Health, 三大智慧生態系創新解決方案,讓您對台灣經濟產生新認知。
下午論壇中,我們特別邀請美國 Insilico Medicine、SmartLabs、Elemental Machines、及NAVIDA,針對AI和數位醫療保健尖端技術進行討論與分享。
我們希望透過本次會議能刺激生物技術與 ICT 領域之間的合作,同時成功吸引主要的國際企業到台灣投資。如果您是關心科技、創業、投資業界人士,誠摯邀請您一同見證創新智慧生態系的改革!
SmartLabs Startup Showcase
Presentations from Emerging Taiwanese Life Science Startups. Come hear how SmartLabs Global Launch Companies are Driving Innovation at the Forefront of Medical Devices, Therapeutics, Digital Heath, and Al Driven Platforms for the Pharma and Healthcare Industry.
SmartLabs Forum Al and Digital Technology in Pharma and Healthcare
Presentations from Industry Leaders Working on Groundbreaking Developments in Al and Digital Health in the Pharma and Healthcare Industry.
12月04日我們將推舉21家優秀新創,一同向您展示 Medical Device、Therapeutics、Digital Health, 三大智慧生態系創新解決方案,讓您對台灣經濟產生新認知。
下午論壇中,我們特別邀請美國 Insilico Medicine、SmartLabs、Elemental Machines、及NAVIDA,針對AI和數位醫療保健尖端技術進行討論與分享。
我們希望透過本次會議能刺激生物技術與 ICT 領域之間的合作,同時成功吸引主要的國際企業到台灣投資。如果您是關心科技、創業、投資業界人士,誠摯邀請您一同見證創新智慧生態系的改革!
SmartLabs Startup Showcase
Presentations from Emerging Taiwanese Life Science Startups. Come hear how SmartLabs Global Launch Companies are Driving Innovation at the Forefront of Medical Devices, Therapeutics, Digital Heath, and Al Driven Platforms for the Pharma and Healthcare Industry.
- Time: 09:30 - 12:30 +
- Location: Room 505A, Taipei Nangang Exhibition Center
SmartLabs Forum Al and Digital Technology in Pharma and Healthcare
Presentations from Industry Leaders Working on Groundbreaking Developments in Al and Digital Health in the Pharma and Healthcare Industry.
- Time : 13:30 - 17:30
- Location: Room 501, Taipei Nangang Exhibition Center
活動議程
SmartLabs Startup Showcase
Time | Event |
09:30 - 09:40 | Welcome |
All Star Showcase | |
09:40 - 09:55 | APrevent Medical |
09:55 - 10:10 | ATP Biopharm |
10:10 - 10:25 | Instant NanoBiosensors |
10:25 - 10:40 | TRUST Bio-sonics |
10:40 - 11:00 | Anbogen Therapeutics |
Medical Device Section | |
11:00 - 11:06 | Brain Navi Biotechnology |
11:06 - 11:12 | MTAM Tech |
11:12 - 11:18 | Cell Envision |
11:18 - 11:24 | Hawk Scientific |
11:24 - 11:30 | Taipeibio |
Therapeutics Section | |
11:30 - 11:36 | Acura Nanomedicine |
11:36 - 11:42 | NHRI Spin-off Vaccine Company |
11:42 - 11:48 | Cancerfree Biotech |
11:48 - 11:54 | twHerb Biomedical |
Digital Health Section | |
11:54 - 12:00 | Yuan Consulting |
12:00 - 12:06 | Cloudmed Al |
12:06 - 12:12 | Arvin Bio-Medical Device |
12:12 - 12:18 | Laboratory of Precision Psychiatry |
Al and Digital Technology in Pharma & Healthcare
Time | Event |
13:30 - 13:45 | Opening Remarks |
13:45 - 14:30 | Clara, an Al-powered Application Framework for Life Sciences and Healthcare Eddie Huang, Solution Architect Director, Healthcare, APAC, NVIDIA |
14:30 - 15:15 | Practical Applications of Al in Deciphering Disease Mechanisms and Discovering Novel Small Molecules Outside the known Chemical Space Alex Zhavoronkov, Founder and CEO, Insilico Medicine |
15:15 - 15:45 | Refreshment / Bio Break |
15:45 - 16:30 | Applications of Al in Clinical Trials and in the Pharmaceutical Industry Ronald Dorenbos, Director of Business Development, SmartLabs Former Head Innovation Management & Scouting at Takeda Pharmaceuticals |
16:30 - 17:15 | Use of Al to Extract Maximum Value from Enterprise Data, Increase Efficiency, and Optimize Processes Sridhar lyengar, CEO & Founder, Elemental Machines Founder of Misfit & AgaMatrix |
17:15 - 17:30 | Closing Remarks |